Mechanisms of Cellular and Molecular Responses toAcute Hypoxia in Vascular Cells

博士 === 臺北醫學大學 === 臨床醫學研究所 === 97 === The aim of this thesis is to investigate the responses of vascular cells, including endothelial cells (ECs) and smooth muscle cells (VSMCs), to acute hypoxia and the underlying molecular mechanisms. Discoidin domain receptor-2 (DDR2) is a receptor tyrosine kinase...

Full description

Bibliographic Details
Main Authors: Shih-Chung Chen, 陳識中
Other Authors: 徐國基
Format: Others
Language:en_US
Published: 2008
Online Access:http://ndltd.ncl.edu.tw/handle/54755600841899224005
Description
Summary:博士 === 臺北醫學大學 === 臨床醫學研究所 === 97 === The aim of this thesis is to investigate the responses of vascular cells, including endothelial cells (ECs) and smooth muscle cells (VSMCs), to acute hypoxia and the underlying molecular mechanisms. Discoidin domain receptor-2 (DDR2) is a receptor tyrosine kinase that binds to the extracellular matrix. We first investigated the role of hypoxia in DDR2 expression in VSMCs and the underlying mechanism. Subjecting VSMCs to hypoxia induced DDR2 expression; treatments with a specific inhibitor (SB203580) of p38 mitogen-activated protein kinase (MAPK) or p38-specific small interference RNA (siRNA) abolished this hypoxia-induced DDR2 expression. Gel shifting assays showed that hypoxia increased the Myc–Max–DNA binding activity in the promoter region of DDR2; inhibition of p38 MAPK activation by SB203580 and p38-specific siRNA blocked hypoxia-induced DDR2 promoter activity. Hypoxia also induced matrix metalloproteinase-2 (MMP-2) activity in VSMCs and increased their migration. These VSMC responses to hypoxia were inhibited by DDR2- and p38-specific siRNAs. Our results suggested that hypoxia induces DDR2 expression in VSMCs at the transcriptional level, which is mediated by the p38 MAPK pathway and contributes to VSMC migration.Since activating transcription factor 3 (ATF3), a stress-inducible transcription factor playing significant roles in cellular responses to stress, including hypoxia, we further investigated the role of ATF3 in cellular responses to hypoxia. Vascular ECs were subjected to acute hypoxia and ATF3 expression was examined. ECs exposed to hypoxia transiently induced ATF3 expression. A transient increase in the activation of c-Jun-NH2-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) in ECs was observed; however, only ECs pretreated with a specific inhibitor to JNK suppressed the hypoxia-induced ATF3 expression. ECs exposed to acute hypoxia transiently increased endothelial nitric oxide synthase (eNOS) activity. Pre-treating ECs with a specific inhibitor to eNOS (L-NAME) or PI3-kinase significantly inhibited the hypoxia-induced JNK activation and ATF3 expression. ATF3 induction has been shown to inhibit matrix metalloproteinase-2 (MMP-2) expression. Consistently, ECs exposed to hypoxia attenuated the MMP-2 expression. These results suggest that the ATF3 induction by acute hypoxia is mediated by nitric oxide and the JNK pathway in ECs. Recent studies indicated that protein S-nitrosylation (S-NO) plays an important role in regulating proteins’ function and thus is of significance in cell physiology. We further investigated the effect of hypoxia on EC S-NO. A modified biotin-switch method coupled with proteomic approach demonstrated that at least 11 major proteins have significant increase in S-NO in ECs after acute hypoxia. Mass analysis by CapLC/Q-TOF identified those as Ras-GTPase-activating protein, protein disulfide-isomerase, human elongation factor-1-delta, tyrosine 3/tryptophan 5-monooxygenase activating protein, and several cytoskeleton proteins. Further understanding of the functional relevance of these S-nitrosylated proteins and the previous findings of DDR2 and ATF3 activities may provide a molecular basis for understanding the ischemia-induced vascular physiologies.